Latest Annual Report
Filed: 2026-02-27
Key Insights
- Chemed Corporation's 10-K filing for fiscal year 2025 indicates continued revenue growth and profitability in its Vitas healthcare segment, driven by strong performance in routine home care, inpatient care, and care services across Medicare, Medicaid, and commercial insurance payers.
- The company's Roto-Rooter segment also shows positive trends, with increases in revenue from water restoration, short-term core service jobs, and plumbing services.
- Chemed has maintained a consistent capital allocation strategy, including the use of treasury stock and share-based compensation programs to incentivize and retain key employees.